Genprex Collaborators To Present Preclinical Data On Use Of Reqorsa And On NPRL2 Gene Therapy Utilizing Non-Viral Oncoprex Delivery System For Lung Cancers At 2024 AACR Annual Meeting
Genprex Collaborators To Present Preclinical Data On Use Of Reqorsa And On NPRL2 Gene Therapy Utilizing Non-Viral Oncoprex Delivery System For Lung Cancers At 2024 AACR Annual Meeting
Genprex 合作者將在 2024 年 AACR 年會上提供有關使用 Reqorsa 和利用非病毒 Oncoprex 遞送系統治療肺癌的 NPRL2 基因療法的臨床前數據
Reqorsa Immunogene Therapy May be a Potential Therapy for ALK-Positive Lung Cancer
Reqorsa 免疫基因療法可能是 ALK 陽性肺癌的潛在療法
REQORSA has Anti-Tumor Mechanisms that Target and Disrupt the Metabolism of Cancer Cells
REQORSA 具有靶向和破壞癌細胞代謝的抗腫瘤機制
NPRL2 Gene Therapy Induces Effective Anti-Tumor Immunity in Non-Small Cell Lung Cancer Humanized Mouse Model
NPRL2 基因療法在非小細胞肺癌人源化小鼠模型中誘導有效的抗腫瘤免疫